2.18Open2.18Pre Close0 Volume39 Open Interest22.00Strike Price0.00Turnover56.87%IV7.73%PremiumMay 16, 2025Expiry Date0.52Intrinsic Value100Multiplier13DDays to Expiry1.66Extrinsic Value100Contract SizeAmericanOptions Type-0.5620Delta0.1706Gamma17.90Leverage Ratio-0.0340Theta-0.0043Rho-10.06Eff Leverage0.0161Vega
Tandem Diabetes Care Stock Discussion
Breakthrough: Tandem's Control-IQ+ Slashes A1C Levels by 0.9% in Landmark NEJM Study
Revolutionary Diabetes Treatment: Tandem's New Control-IQ+ Expands Access to Automated Insulin Delivery
anyone having any idea why share price dropped like crazy after such a good performance result? especially FDA clearance for type 2 just been received? doesn’t make sense isn’t it?
Tandem's Automated Insulin Technology Breaks New Ground: FDA Approves for Type 2 Diabetes
-- Worldwide GAAP sales increased 13 percent to $221.9 million compared to
second quarter 2023; worldwide non-GAAP sales(1) increased 12 percent to
$221.8 million compared to second quarter 2023.
-- More than 20,000 pumps shipped in the United States, a sequential
increase of 33 percent compared to first quarter 2024.
-- Launched Tandem Mobi with Dexcom G7 continuous glucose monitoring (CGM)
sensor integration in th...
Just check call options. they are expensive
However, stock price moves only 5-10% with no news. Something is going on behind the scene?!
No comment yet